Ocular Therapeutix, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2012 | $-12.6M | $-12.8M | $203.0K | $243.0K |
| FY2013 | $-12.6M | $-13.0M | $387.0K | $476.0K |
| FY2014 | $-20.5M | $-21.8M | $1.3M | $2.6M |
| FY2015 | $-33.7M | $-35.5M | $1.8M | $4.6M |
| FY2016 | $-34.0M | $-35.9M | $1.9M | $6.0M |
| FY2017 | $-50.5M | $-58.7M | $8.3M | $7.3M |
| FY2018 | $-49.2M | $-51.1M | $1.9M | $7.5M |
| FY2019 | $-77.6M | $-79.8M | $2.2M | $8.8M |
| FY2020 | $-53.6M | $-54.4M | $841.0K | $7.5M |
| FY2021 | $-65.6M | $-66.7M | $1.2M | $15.0M |
| FY2022 | $-59.6M | $-63.3M | $3.7M | $17.0M |
| FY2023 | $-70.2M | $-76.3M | $6.1M | $17.8M |
| FY2024 | $-134.7M | $-136.0M | $1.3M | $33.1M |
| FY2025 | $-204.9M | $-216.9M | $12.0M | $43.2M |